# Mylan Technologies, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70

> Inspection records and compliance data for Mylan Technologies, Inc. in Saint Albans, Vermont. Access full analysis and detailed observations.

---

## Details

- Name: Mylan Technologies, Inc.
- FEI Number: 1220747
- City: Saint Albans
- State: Vermont
- Country Name: United States
- Address Line 1: 110 Lake St
- Zip Code: 05478
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [FDA Inspection 1285894 - Mylan Technologies, Inc. - 2025-10-21](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/46d2edf2-7ff7-456d-86b0-daff0f514002) — source: FDA, date: October 21, 2025
- [FDA Inspection 1285894 - Mylan Technologies, Inc. - 2025-10-21](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/a29d2057-31b1-45d9-81e0-09e9e508c214) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2025
- [FDA Inspection 1133997 - Mylan Technologies, Inc. - 2020-11-20](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/668936f7-004a-42f3-9db8-4dfcb7e57bdf) — classification: No Action Indicated (NAI), source: FDA, date: November 20, 2020
- [FDA Inspection 1065833 - Mylan Technologies, Inc. - 2018-08-15](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/e8c618d8-4bb0-4582-8011-05cd6d7740f8) — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2018
- [FDA Inspection 970691 - Mylan Technologies, Inc. - 2016-04-13](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/b70799b8-e3a2-4143-a8b6-018af3914901) — classification: No Action Indicated (NAI), source: FDA, date: April 13, 2016
- [FDA Inspection 836096 - Mylan Technologies, Inc. - 2013-04-30](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/d9903b82-241a-4204-b1a1-19fd6f7feaf2) — classification: No Action Indicated (NAI), source: FDA, date: April 30, 2013
- [FDA Inspection 750943 - Mylan Technologies, Inc. - 2011-10-31](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/16e6cc82-2389-41a2-9d60-54cd0afc029c) — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2011
- [FDA Inspection 667710 - Mylan Technologies, Inc. - 2010-06-04](https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/baa8691b-c8e2-4ef0-9ab4-a12477def4ed) — classification: No Action Indicated (NAI), source: FDA, date: June 4, 2010

## Related Companies

- [Combe Laboratories, Inc.](https://www.keypedia.com/companies/combe-laboratories-inc/165d44db-fdc0-4975-af22-35ec39c2735d)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82)
- [Penn Pharmaceutical Services Limited](https://www.keypedia.com/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/03c10541-23fe-4547-ae02-c47669f35343)
- [Delpharm Huningue S.A.S.](https://www.keypedia.com/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Orion Corporation, Orion Pharma](https://www.keypedia.com/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [S.s.s. Company (international)](https://www.keypedia.com/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e)